RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.

Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14: Shanghai, China Tuesday, March 25, 2025, 15:00 Hrs [IST] Everest Medicines, a biop ...

First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation ...

The team’s vaccine represents a recent shift to more targeted cancer therapies than general treatments like surgery, radiation and chemotherapy that tend to prolong life in advanced cancer patients ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...

The text of the amendment wasn't yet available, but the bill was advanced with the planned ... sold or administered in Iowa unless the vaccine manufacturer waives "immunity from suit for an injury ...